Retinitis Pigmentosa (RP) is a genetic condition causing progressive vision loss that is under-recognised in Somalia due to very limited access to genetic counselling and specialist retina services. Most confirmed diagnoses come through the handful of ophthalmology centres in Mogadishu. Stem Cell Cure India works with Somali patients and families exploring stem cell therapy as a complementary option alongside standard low-vision and ophthalmology support.
Genetic retinal disease diagnosis requires specialist equipment and, ideally, genetic testing — both scarce or unavailable in Somalia. Many Somali RP patients are diagnosed late, after significant night blindness or peripheral vision loss has developed, and consanguineous marriage patterns in some communities can raise the local prevalence of inherited retinal conditions. Families increasingly look to India for specialist retina evaluation and regenerative treatment options not available at home.
Dr. Tyagi leads the regenerative medicine protocol design at Stem Cell Cure India, overseeing stem cell sourcing, lab processing, and treatment planning for patients — including those travelling from Nigeria .
Dr. Pallavee brings over two decades of clinical ophthalmology experience, supporting the eye-specific evaluation and treatment planning for patients undergoing stem cell therapy for retinal and optic nerve conditions at Stem Cell Cure India
Consultant Ophthalmologist & Eye Surgeon
Specialist in advanced cataract surgery, refractive surgery, and Corneal Cross-Linking for Keratoconus with extensive clinical experience.
Associate Professor | Vitreo-Retina Surgeon
Experienced cataract and vitreo-retina surgeon with expertise in retinal disorders, diabetic retinopathy, and advanced retina procedures.
Mesenchymal Stem Cells (MSCs) are being studied for their potential to support surviving retinal cells and slow further degeneration in some RP patients. Stem cell therapy does not reverse retinal cells that have already been lost, and RP remains a progressive genetic condition; treatment is offered as a complementary option to discuss alongside ongoing low-vision support.
Suitability depends on the specific condition and its stage. Before travelling, our team reviews:
No. RP is a progressive genetic condition with no current cure. Stem cell therapy is explored as a complementary option that may help support remaining retinal function.
It is not always required but can help our team understand disease progression. If you haven't had genetic testing, this can be discussed during your initial review.
A recent retinal examination, ERG results if available, and details of your family history and vision changes over time.
Most patients stay 5 to 10 days, depending on diagnostics and the treatment plan.
Yes. Once treatment is confirmed, we provide the invitation and supporting documents Somali citizens need to apply for a Medical Visa.
Source: These are real, verified Google reviews currently published on stemcellcure.in — pulled from our Google Business Profile (5.0★).
Contact Stem Cell Cure India today to share your medical history and get a personalised opinion on suitability.
